The UK’s Hikma Pharmaceuticals has agreed to pay $45.75 million for the Canadian business of Teligent, a US generic drugmaker that filed for Chapter 11 bankruptcy...
05.03.2014
- Up And Up - Long known for its struggles with infectious diseases and poverty, the continent of Africa is experiencing widespread economic growth. An increasing middle class and...
01.03.2013
- Hikma Pharmaceuticals said it is reviewing options for its lucrative injectables business after receiving several unsolicited expressions of interest, driving up its shares nearly...
15.10.2012
- Jordan's Hikma Pharmaceuticals said it is looking to expand in Africa over the next two to three years, through building its own plant or by making an acquisition of up to $300...
